Recent blog posts
SEMA6C Biologics Sequence Review Report 2026: Semaphorin-6C Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
SEMA6C Biologics Sequence Review Report 2026: Semaphorin-6C Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of SEMA6C protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
SEMA6A Biologics Sequence Review Report 2026: Semaphorin-6A Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
SEMA6A Biologics Sequence Review Report 2026: Semaphorin-6A Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of SEMA6A protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
SEMA5B Biologics Sequence Review Report 2026: Semaphorin-5B Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
SEMA5B Biologics Sequence Review Report 2026: Semaphorin-5B Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of SEMA5B protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
LRP8 Biologics Sequence Review Report 2026: Low-density lipoprotein receptor-related protein 8 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
LRP8 Biologics Sequence Review Report 2026: Low-density lipoprotein receptor-related protein 8 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of LRP8 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GPRC6A Biologics Sequence Review Report 2026: G protein-coupled receptor family C group 6 member A Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
GPRC6A Biologics Sequence Review Report 2026: G protein-coupled receptor family C group 6 member A Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of GPRC6A protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
ICAM5 Biologics Sequence Review Report 2026: Intercellular adhesion molecule 5 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
ICAM5 Biologics Sequence Review Report 2026: Intercellular adhesion molecule 5 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of ICAM5 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
IL16 Biologics Sequence Review Report 2026: Pro-interleukin-16 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
IL16 Biologics Sequence Review Report 2026: Pro-interleukin-16 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of IL16 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
ERBB4 Biologics Sequence Review Report 2026: Receptor tyrosine-protein kinase erbB-4 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
ERBB4 Biologics Sequence Review Report 2026: Receptor tyrosine-protein kinase erbB-4 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of ERBB4 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GPRASP1 Biologics Sequence Review Report 2026: G protein-coupled receptor-associated sorting protein 1 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
GPRASP1 Biologics Sequence Review Report 2026: G protein-coupled receptor-associated sorting protein 1 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of GPRASP1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
ERBB3 Biologics Sequence Review Report 2026: Receptor tyrosine-protein kinase erbB-3 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
ERBB3 Biologics Sequence Review Report 2026: Receptor tyrosine-protein kinase erbB-3 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of ERBB3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GPR158 Biologics Sequence Review Report 2026: Metabotropic glycine receptor Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
GPR158 Biologics Sequence Review Report 2026: Metabotropic glycine receptor Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of GPR158 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
ERBB2 Biologics Sequence Review Report 2026: Receptor tyrosine-protein kinase erbB-2 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
ERBB2 Biologics Sequence Review Report 2026: Receptor tyrosine-protein kinase erbB-2 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of ERBB2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →